TRB Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
TRB Wealth Management's ABBV Position: Q3 2026 in Review
TRB Wealth Management increased its AbbVie (ABBV) stake by 1.1% in Q3 2026, buying an estimated $22.6K and bringing the position to 7,915 shares worth $2.07M. The position accounts for 0.29% of the portfolio, ranked #54.
TRB Wealth Management first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.79M in Q1 2026. 4,273 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- TRB Wealth Management held 7,915 shares of AbbVie worth $2.07M as of Q3 2026.
- TRB Wealth Management bought 88 AbbVie shares in Q3 2026, an estimated $22.6K.
- AbbVie made up 0.29% of TRB Wealth Management's portfolio in Q3 2026, its #54 holding.
- TRB Wealth Management first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
- TRB Wealth Management's AbbVie position peaked at $2.79M in Q1 2026.
- 4,273 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on TRB Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.